Daily Management: Diet and Medical Therapies for MTP Deficiency
At a Glance
Daily management of MTP deficiency requires strict avoidance of fasting, a specialized low-fat and high-carbohydrate diet, and alternative fuels like MCT oil or Dojolvi. Working closely with a metabolic team is critical to maintain steady energy levels and prevent severe metabolic crises.
Managing Mitochondrial Trifunctional Protein (MTP) deficiency every day is a balancing act. Because the body cannot properly turn long-chain fats into energy, the goal of treatment is twofold: provide alternative fuel sources and prevent the body from ever needing to “tap into” its own fat stores [1][2].
The Foundation: Avoiding Fasting
The most critical part of daily life is the fasting interval—the maximum amount of time a person can safely go without eating. When a person with MTP deficiency fasts too long, the body begins to break down its own fat for energy, which triggers an energy crisis and the buildup of toxic intermediates [1][3].
- Infants: Often need to eat every 3 to 4 hours, even through the night.
- Older Children and Adults: May have longer intervals, but even then, missed meals or late snacks can be dangerous [1].
- Nighttime Management: To bridge the long gap of sleep, many families use uncooked cornstarch (which releases energy slowly over several hours) or a gastrostomy tube (G-tube) for continuous nighttime feeding [4].
- Important Warning: Uncooked cornstarch is ONLY safe for older children (typically over 6 to 12 months, as strictly directed by a doctor). Infants lack the digestive enzymes to process it, and giving it to them can cause severe gastrointestinal distress and actually trigger a metabolic crisis [5].
The MTP Diet: Low-Fat, High-Fuel
The standard diet for MTP deficiency is very specific and requires the guidance of a metabolic dietitian. It is generally low-fat (specifically low in long-chain fats) and high-carbohydrate [6][5].
- Restricted Fats: Foods naturally high in long-chain fats—like most oils, butter, whole dairy, and fatty meats—are strictly limited because the body cannot process them [6][7].
- Practical Tip: Nutrition labels usually only list “Total Fat” or “Saturated Fat”—they do not explicitly list “long-chain fats.” You must work closely with a metabolic dietitian to identify safe foods and safely read ingredient labels.
- Essential Fatty Acid (EFA) Needs: Because you are avoiding natural fats, you or your child are at high risk for Essential Fatty Acid deficiency. These are specific fats (like linoleic and alpha-linolenic acids) that the body requires for brain development, skin health, and growth. Your doctor will prescribe carefully calculated EFA supplements to prevent deficiency [8].
- Essential Carbohydrates: Complex carbohydrates (grains, fruits, vegetables) provide the steady stream of glucose the body needs to keep running [5].
Medical Oils: Bypassing the Block
Since the body cannot use long-chain fats, doctors prescribe “short-cut” fuels that bypass the broken MTP enzyme complex.
Medium-Chain Triglyceride (MCT) Oil
MCT oil is a common supplement. Unlike long-chain fats, MCTs do not need the MTP enzyme to be turned into energy. They provide an immediate alternative fuel source for the heart and muscles [6][9].
Triheptanoin (Dojolvi)
Triheptanoin is a newer, FDA-approved medication for long-chain fatty acid oxidation disorders [10]. While it is a type of oil, it works differently than standard MCT oil:
- Anaplerotic Support: It provides a specific type of fuel (heptanoate) that goes directly into the “power plant” of the cell (the TCA cycle or Krebs cycle) [11][12].
- Benefits: Studies show it can reduce the number of metabolic crises and hospitalizations by helping the cells maintain more stable energy production [13][14].
The L-Carnitine Discussion
L-carnitine is a supplement often used in metabolic disorders to help move fats into the mitochondria and clear out waste products [15]. However, its use in MTP deficiency and other long-chain disorders is a subject of ongoing discussion among experts [16].
Some doctors believe it helps detoxify the system, while others worry that in specific conditions, it might actually contribute to muscle breakdown (rhabdomyolysis) [17][16]. Because of this, your doctor will decide whether to use it based on your or your child’s specific blood levels and clinical history.
Precision is Key
Daily management requires precision. Doses of MCT oil or triheptanoin are usually divided throughout the day and given with every meal or snack to ensure a constant supply of energy [13]. Your metabolic team will provide a detailed plan tailored to age, weight, and activity level [4].
Common questions in this guide
Why is avoiding fasting so critical for MTP deficiency?
What foods are restricted on the MTP deficiency diet?
Can babies with MTP deficiency use uncooked cornstarch at night?
How do MCT oil and Dojolvi help treat MTP deficiency?
Why are essential fatty acid supplements necessary?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is the exact maximum safe fasting interval for me or my child at our current age, both during the day and overnight?
- 2.What percentage of total daily calories should come from long-chain fats versus MCT oil or triheptanoin?
- 3.Do you recommend triheptanoin (Dojolvi) over standard MCT oil for our specific situation, and what are the potential benefits and side effects?
- 4.How are you monitoring my or my child's Essential Fatty Acid levels to ensure we do not develop a deficiency?
- 5.Given the varying opinions on L-carnitine for long-chain disorders, what is your approach for this specific condition?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (17)
- 1
Inborn Errors of Metabolism with Myopathy: Defects of Fatty Acid Oxidation and the Carnitine Shuttle System.
El-Gharbawy A, Vockley J
Pediatric clinics of North America 2018; (65(2)):317-335 doi:10.1016/j.pcl.2017.11.006.
PMID: 29502916 - 2
Recent Advances in the Pathophysiology of Fatty Acid Oxidation Defects: Secondary Alterations of Bioenergetics and Mitochondrial Calcium Homeostasis Caused by the Accumulating Fatty Acids.
Amaral AU, Wajner M
Frontiers in genetics 2020; (11()):598976 doi:10.3389/fgene.2020.598976.
PMID: 33329744 - 3
Regulatory news: Dojolvi (triheptanoin) as a source of calories and fatty acids in long-chain fatty acid oxidation disorders: FDA approval summary.
Zand D, Doan J, Yi S, et al.
Journal of inherited metabolic disease 2021; (44(3)):515-517 doi:10.1002/jimd.12377.
PMID: 33729583 - 4
Nutritional Management of Patients with Fatty Acid Oxidation Disorders.
Peña-Quintana L, Correcher-Medina P
Nutrients 2024; (16(16)) doi:10.3390/nu16162707.
PMID: 39203843 - 5
Early diagnosis and treatment by newborn screening (NBS) or family history is associated with improved visual outcomes for long-chain 3-hydroxyacylCoA dehydrogenase deficiency (LCHADD) chorioretinopathy.
Gillingham MB, Choi D, Gregor A, et al.
Journal of inherited metabolic disease 2024; (47(4)):746-756 doi:10.1002/jimd.12738.
PMID: 38623632 - 6
Neonatal Long-Chain 3-Ketoacyl-CoA Thiolase deficiency: Clinical-biochemical phenotype, sodium-D,L-3-hydroxybutyrate treatment experience and cardiac evaluation using speckle echocardiography.
Veenvliet ARJ, Garrelfs MR, Udink Ten Cate FEA, et al.
Molecular genetics and metabolism reports 2022; (31()):100873 doi:10.1016/j.ymgmr.2022.100873.
PMID: 35782614 - 7
Periodic Paralysis in a Child With Thermosensitive Mitochondrial Trifunctional Protein Deficiency.
Al-Amrani F, Ruiter JPN, Doolaard M, et al.
American journal of medical genetics. Part A 2025; (197(2)):e63900 doi:10.1002/ajmg.a.63900.
PMID: 39360520 - 8
Ophthalmic Symptoms of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency: A Report of Three Cases.
Lange N, Bodetko AM, Mozrzymas R, Kowal-Lange A
Case reports in ophthalmology 2024; (15(1)):310-319 doi:10.1159/000537895.
PMID: 38595698 - 9
Diagnosis, Treatment, and Clinical Outcome of Patients with Mitochondrial Trifunctional Protein/Long-Chain 3-Hydroxy Acyl-CoA Dehydrogenase Deficiency.
De Biase I, Viau KS, Liu A, et al.
JIMD reports 2017; (31()):63-71 doi:10.1007/8904_2016_558.
PMID: 27117294 - 10
Medium branched chain fatty acids improve the profile of tricarboxylic acid cycle intermediates in mitochondrial fatty acid β-oxidation deficient cells: A comparative study.
Karunanidhi A, Van't Land C, Rajasundaram D, et al.
Journal of inherited metabolic disease 2022; (45(3)):541-556 doi:10.1002/jimd.12480.
PMID: 35076099 - 11
Ketogenic and anaplerotic dietary modifications ameliorate seizure activity in Drosophila models of mitochondrial encephalomyopathy and glycolytic enzymopathy.
Fogle KJ, Smith AR, Satterfield SL, et al.
Molecular genetics and metabolism 2019; (126(4)):439-447 doi:10.1016/j.ymgme.2019.01.008.
PMID: 30683556 - 12
A pharmacological profile of triheptanoin for the treatment of long-chain fatty acid oxidation disorders.
Forsyth R, Vockley J
Expert review of clinical pharmacology 2025; (18(7)):449-460 doi:10.1080/17512433.2025.2528835.
PMID: 40633017 - 13
The effect of triheptanoin treatment on clinical and laboratory outcomes in patients with long-chain fatty acid oxidation disorder.
Köse E, İnci A, Yazıcı H, et al.
European journal of pediatrics 2025; (184(6)):382 doi:10.1007/s00431-025-06216-3.
PMID: 40448841 - 14
Major clinical events and healthcare resource use among patients with long-chain fatty acid oxidation disorders in the United States: Results from LC-FAOD Odyssey program.
Yang E, Kruger E, Yin D, et al.
Molecular genetics and metabolism 2024; (142(1)):108350 doi:10.1016/j.ymgme.2024.108350.
PMID: 38458123 - 15
Carnitine Deficiency in Chronic Kidney Disease: Pathophysiology, Clinical Implications, and Therapeutic Perspectives.
Kaida Y, Taguchi K, Fukami K
Nutrients 2025; (17(13)) doi:10.3390/nu17132084.
PMID: 40647189 - 16
Efficacy of bezafibrate in two patients with mitochondrial trifunctional protein deficiency.
Suyama T, Shimura M, Fushimi T, et al.
Molecular genetics and metabolism reports 2020; (24()):100610 doi:10.1016/j.ymgmr.2020.100610.
PMID: 32509533 - 17
Two siblings with very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency suffered from rhabdomyolysis after l-carnitine supplementation.
Watanabe K, Yamada K, Sameshima K, Yamaguchi S
Molecular genetics and metabolism reports 2018; (15()):121-123 doi:10.1016/j.ymgmr.2018.03.007.
PMID: 30023301
This page explains dietary and medical management for MTP deficiency for educational purposes only. Always consult your metabolic dietitian and genetics team before altering feeding schedules or supplements.
Get notified when new evidence is published on Mitochondrial trifunctional protein deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.